Eila C. Skinner
Academic Appointments
- Professor - Med Center Line, Urology
Key Documents
Contact Information
-
Clinical Offices
Urologic Oncology 875 Blake Wilbur Dr Room 2200 MC 5826 Stanford, CA 94305 Tel Work (650) 725-5544 Fax (650) 723-0765
- Academic Offices
Personal Information Email Tel (650) 724-3332Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Urologic Oncology
- Cancer > urologic oncology
- Bladder Cancer
- Continent urinary reservoir
- urinary tract reconstruction
- testis cancer
Administrative Appointments
- Chair, Department of Urology (2012 - present)
Honors and Awards
- Outstanding Teacher Award, Keck USC School of Medicine (1997, 98, 2000, 02, 03, 06, 11)
- Faculty Teacher of the Year, USC Department of Urology (1991, 1994, 1997, 2005)
- Janet M. Glasgow Award for Academic Excellence, USC School of Medicine (1983)
- Alpha Omega Alpha, USC School of Medicine (1982)
- Phi Beta Kappa, Stanford University (1976)
Professional Education
| Fellowship: | USC Norris Comprehensive Cancer Center CA (1990) |
| Internship: | USC/LAC Medical Center CA (1984) |
| Medical Education: | Keck School of Medicine, University of Southern CA CA (1983) |
| Board Certification: | American Board of Urology, Urology (1992) |
| Fellowship: | USC Norris Comprehensive Cancer Center, Urologic Oncology (1990) |
| Residency: | LAC+USC Medical Center, Urology (1988) |
Graduate & Fellowship Program Affiliations
Community and International Work
- "Real Men Cook" Foundation, Los Angeles
Internet Links
Scientific Focus
Current Research Interests
My research focuses on outcomes in treatment of muscle invasive and high-grade non-muscle invasive bladder cancer. This includes identifying markers of prognosis, predictive markers for response to surgery and chemotherapy, and working toward an individualized, multidisciplinary approach to disease management. We are particularly interested in the impact of surgical quality measures on outcome for patients with invasive disease. I have also focused on optimizing the use of lower urinary tract reconstruction in patients undergoing cystectomy, and identifying interventions to improve patient quality of life. This has included a large prospective randomized study of two alternative forms of continent neobladder, and evaluating the effect of prior radiation or chemotherapy on the outcome with this surgery. We continue to follow these patients long term to evaluate renal function and complications, and to mine the rich data from this trial to better understand the long term outcomes with this reconstructive surgery. We are also using the outcomes of this trial to design early interventions to avoid complications and improve patient quality of life after the operation.
Publications
- Critical evaluation of the American Joint Committee on Cancer TNM nodal staging system in patients with lymph node-positive disease after radical cystectomy. Eur Urol. 2012; (4): 671-6
- Factors influencing post-recurrence survival in bladder cancer following radical cystectomy. BJU Int. 2012; (6): 846-54
- Robotic and laparoscopic high extended pelvic lymph node dissection during radical cystectomy: technique and outcomes. Eur Urol. 2012; (2): 350-5
- Choosing the right urinary diversion: patient's choice or surgeon's inclination? Urol Oncol. 2011 Sep-Oct; (5): 473-5
- Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study European Urology. 2011: 946
- Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol. 2011; (4): 1261-8
Help
Trial Administration